Should Access to Scientific Research Be Free?

journals

Federally-Funded Research Might Someday Be Free A New Scientist article by Graham Lawton predicts that, by January 1, 2030, all biomedical research will be free to read. That might be an overly ambitious goal. It might not be a good idea, either. If research is federally funded, then perhaps — as Boingboing suggests — the…

Read More

What Senator Ed Markey Doesn’t Understand

Senate

Senator Ed Markey of MA Opposed DSUVIA According to a recent USA Today article, Senator Ed Markey of Massachusetts “urged the FDA not to approve Dsuvia last month, saying “an opioid that is a thousand times more powerful than morphine is a thousand times more likely to be abused, and a thousand times more likely to…

Read More

Beyond Midterms

politicians

What’s Next? Midterms are behind us. You may be pleased or displeased with the results. Either way, the newly elected, and the reelected, senators and members of congress will now determine healthcare policy. They will take office in January. In the meantime, do your homework. When you’re worried that your doctor might be pressured to…

Read More

Get Out to Vote

I Voted - Voting Day

Vote to Change Healthcare Policies Mid-term elections are approaching. If you have the ability to vote, then this is a chance to help determine the direction of our healthcare policies. There are many issues important to each of us. To people who follow my blog, the most important healthcare issues have to do with how…

Read More

Personalized Pain Medicine

Personalized Pain Medicine

Below is an edited excerpt from a chapter titled, Pharmacogenetics and Personalized Medicine in Pain Management, that Inna Belfer, MD PhD and I published in Clinics in Laboratory Medicine, Volume 36, Issue 3, September 2016.  Personalized Pain Medicine Pharmacogenetic therapy in people with pain requires consideration of 2 different genetic substrates to determine the outcome…

Read More

My Testimony Before the ADCOM for AcelRex’s DSUVIA

ADCOM

On Friday, Oct. 12, 2018, AcelRex Pharmaceuticals, Inc. presented its case to the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (ADCOM) to discuss the approval of the new drug application (NDA) 209128 for DSUVIA™. DSUVIA is a small sufentanil pill deposited below the tongue with an applicator. It is…

Read More

How Smart Is It to Take Smart Drugs?

This is an article by Stacey J. Miller. I offer it with the author’s permission for informational purposes. THE VIEWS EXPRESSED BY THE AUTHOR ARE HER OWN AND DO NOT REPRESENT MY VIEW OR MEDICAL ADVICE. The Myth of Brain Power If you hear something often enough, you may start to believe it. Most of…

Read More

Football and Brain Trauma

Football and Brain Trauma

Football’s Risks It’s just a “ding,” the coach would tell the parents. “He will be fine. He needs to be a man and get tougher. Everything is fine.” This is what I heard growing up in a place where football was valued more than religion. In fact, it was our religion. Unfortunately, we now know…

Read More